SCHEMBL7647196

SCHEMBL7647196

CCC(C)OP(=O)(O)c1cc2cc(S(=O)(=O)NC)c(Cl)cc2[nH]c1=O

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.33
TAS2R14 Q9NYV8 1/20 0.32
GRIN1 Q05586 3/20 0.32
GRIN2D O15399 2/20 0.32
GRIN3B O60391 2/20 0.32
GRIN2A Q12879 2/20 0.32
GRIN2B Q13224 2/20 0.32
GRIN2C Q14957 2/20 0.32
GRIN3A Q8TCU5 2/20 0.32
GRIA1 P42261 1/20 0.31
GRIA2 P42262 1/20 0.31
GRIA3 P42263 1/20 0.31
GRIA4 P48058 1/20 0.31
ATM Q13315 1/20 0.31
GSTO1 P78417 1/20 0.30
APP P05067 1/20 0.30
TP53 P04637 1/20 0.30
TSHR P16473 1/20 0.30
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7648022 0.92 GRIN1 (0.32) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7647655 0.91 ATM (0.34) KMT2AGRIN1GRIN2DGRIN3BGRIN2A
SCHEMBL7645912 0.91 GSTO1 (0.34) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7646330 0.90 GRIN1 (0.31) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7647833 0.90 POLB (0.33) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL6926212 0.89 GRIN1 (0.33) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL6926878 0.88 CA1 (0.36) GRIN1GRIN2DGRIN3BGRIN2AGRIN2B
SCHEMBL7647481 0.88 SMN1; SMN2 (0.35) KMT2ATSHR
SCHEMBL7652397 0.88 CA12 (0.35) KMT2AATMGSTO1APPTP53
SCHEMBL7646351 0.87 WDR5 (0.39) KMT2AGRIN1GRIN2DGRIN3BGRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6486143-B2 NERVOUS SYSTEM DISORDERS; PSYCHOLOGICAL DISORDERS LES LABORATOIRES SERVIER (FR) 2002-11-26 US disclosed
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds LES LABORATOIRES SERVIER (FR) 2001-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010031746-A1 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds CA6, P2RY6, FPR3 KMT2A 3293/4885TAS2R14 2428/4885GRIN1 801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.